GO:0038092 nodal signaling pathway: Embryonic Axis Formation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038092 nodal signaling pathway is the biological process initiated by Nodal protein binding to an activin receptor on the target cell surface, culminating in regulation of downstream cellular processes such as transcription.
• Nodal signaling is a conserved TGF-β superfamily pathway that establishes dorso-ventral and left-right axes in deuterostomes.
• Core signal transduction proceeds through activin receptor serine/threonine kinases, SMAD2/3 phosphorylation, SMAD4 complex formation, and nuclear transcriptional regulation.
• Nodal signaling is essential for mesoderm and endoderm specification, notochord formation, and left-right asymmetry during vertebrate development.
• Dysregulated Nodal signaling is implicated in cancer progression, including vasculogenic mimicry in breast cancer via the Smad2/3 pathway.
• Nodal signaling intersects with pluripotency networks, BMP signaling, and metabolic regulators such as PCSK9 in human induced pluripotent stem cells.
Description
The nodal signaling pathway (GO:0038092) is a conserved intercellular signaling cascade that plays a central role in early embryonic development and tissue patterning across deuterostomes. It is initiated when Nodal, a member of the TGF-β superfamily, binds to activin receptors on the surface of target cells, leading to activation of intracellular SMAD effectors and changes in gene transcription. This pathway is best known for its functions in mesoderm and endoderm induction, establishment of the dorso-ventral axis, and specification of left-right asymmetry. Because of its fundamental roles in development, nodal signaling has become a major focus for researchers studying stem cell differentiation, organogenesis, and cancer biology. Understanding the molecular components and regulatory logic of this pathway is essential for designing experiments that manipulate cell fate and model human disease.
nodal signaling pathway At A Glance
| GO ID | GO:0038092 |
|---|---|
| GO term | nodal signaling pathway |
| Ontology | biological_process |
| Synonym | nodal signaling, nodal signalling pathway |
| Definition | The series of molecular signals initiated by nodal protein binding to an activin receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| Major function | Embryonic axis formation, mesoderm and endoderm induction, left-right asymmetry, and regulation of transcription |
| Key ligands | Nodal, GDF1, GDF3 |
| Key receptors | Activin receptor type I (ACVR1B/ALK4), Activin receptor type II (ACVR2A/ACVR2B) |
| Key intracellular effectors | SMAD2, SMAD3, SMAD4 |
| Conservation | Conserved in deuterostomes for dorso-ventral and left-right axis establishment |
What Is GO:0038092?
According to the Gene Ontology, GO:0038092 nodal signaling pathway is defined as the series of molecular signals initiated by nodal protein binding to an activin receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, for example transcription. In other words, it is the entire sequence from extracellular Nodal ligand recognition by activin receptors through intracellular signal transduction to changes in target cell behavior or gene expression.
Why Is nodal signaling pathway Important in Cell Biology?
The nodal signaling pathway is critically important because it governs some of the earliest and most fundamental cell fate decisions in vertebrate embryos, including the formation of mesoderm and endoderm, the establishment of the notochord, and the specification of left-right body asymmetry. Disruption of nodal signaling leads to severe developmental defects, while its inappropriate reactivation contributes to cancer progression and other pathological states. Moreover, nodal signaling intersects with pluripotency networks and metabolic regulators in stem cells, making it a key pathway for regenerative medicine and disease modeling.
• Controls mesoderm and endoderm induction during gastrulation.
• Establishes dorso-ventral and left-right axes in deuterostomes.
• Required for notochord formation and axial elongation.
• Regulates pluripotency and BMP signaling in mouse embryonic stem cells.
• Modulated by PCSK9 in human induced pluripotent stem cells, linking metabolism to nodal signaling.
• Promotes vasculogenic mimicry in breast cancer through Smad2/3.
• Involved in placental development and diabetic pregnancy complications.
• Cross-talks with other signaling pathways such as TGF-β/Smad and MAPK.
• Provides a paradigm for studying TGF-β superfamily signal transduction.
• Serves as a target for directed differentiation protocols in stem cell research.
What Happens During nodal signaling pathway?
Ligand binding and receptor activation
In simple terms: Nodal protein acts like a key that fits into activin receptors on the cell surface, turning them on.
The nodal signaling pathway begins when Nodal, a secreted TGF-β family ligand, binds to a complex of type I and type II activin receptors on the surface of a target cell. This binding brings the receptors together and allows the type II receptor kinase to phosphorylate and activate the type I receptor kinase, typically ACVR1B (ALK4).
SMAD2/3 phosphorylation and complex formation
In simple terms: Activated receptors add phosphate tags to SMAD2 and SMAD3 proteins, which then team up with SMAD4.
Once activated, the type I receptor phosphorylates receptor-regulated SMADs, primarily SMAD2 and SMAD3, at their C-terminal serine residues. Phosphorylated SMAD2/3 then forms a heteromeric complex with the common mediator SMAD4, which is essential for nuclear translocation.
Nuclear translocation and transcriptional regulation
In simple terms: The SMAD complex moves into the nucleus and switches target genes on or off.
The SMAD2/3-SMAD4 complex translocates into the nucleus, where it binds to DNA either directly or through interactions with other transcription factors, thereby regulating the expression of target genes that control cell fate, proliferation, and differentiation. This transcriptional output is the downstream cellular process that defines the endpoint of GO:0038092.
Feedback regulation and cross-talk
In simple terms: The pathway can be tuned up or down by other signals and by its own inhibitors.
Nodal signaling is subject to negative feedback by inhibitory SMADs (SMAD6/7) and by extracellular antagonists such as Lefty and Cerberus. It also cross-talks with other pathways, including BMP, Wnt, and MAPK, which modulate the intensity and duration of the signal. In stem cells, Nodal signaling regulates the BMP pluripotency pathway, illustrating pathway integration.
Role in axis formation and notochord development
In simple terms: Nodal signaling helps decide the front-back and left-right orientation of the embryo and builds the notochord.
In deuterostomes, nodal signaling is a conserved mechanism for establishing dorso-ventral and left-right axes. Timely inhibition of TGF-β signaling, which includes nodal-like signals, is required for notochord induction, as shown in recent studies. These developmental roles highlight the pathway's importance in early embryogenesis.
Key Genes Involved in GO:0038092 nodal signaling pathway
The following genes and proteins are core components or well-documented modulators of the nodal signaling pathway (GO:0038092).
| Gene | Major Role | Research Relevance |
|---|---|---|
| NODAL | Extracellular ligand that initiates the pathway | Knockout causes severe mesoderm defects; key for stem cell differentiation |
| ACVR1B (ALK4) | Type I activin receptor kinase | Mediates SMAD2/3 phosphorylation; target for pathway inhibition |
| ACVR2A | Type II activin receptor kinase | Activates type I receptor; essential for signal initiation |
| ACVR2B | Type II activin receptor kinase | Alternative type II receptor; involved in left-right asymmetry |
| SMAD2 | Receptor-regulated SMAD; transducer | Phosphorylated by receptor; forms complex with SMAD4 |
| SMAD3 | Receptor-regulated SMAD; transducer | Mediates transcriptional responses; linked to cancer |
| SMAD4 | Common mediator SMAD | Required for nuclear translocation of SMAD2/3 |
| FOXH1 | Forkhead transcription factor | Binds SMAD2/3 to activate target genes |
| LEFTY1 | Extracellular antagonist | Negative feedback inhibitor of Nodal signaling |
| LEFTY2 | Extracellular antagonist | Involved in left-right patterning |
| CER1 | Extracellular antagonist | Inhibits Nodal signaling during gastrulation |
| GDF1 | Nodal-like ligand | Cooperates with Nodal in axis formation |
| GDF3 | Nodal-like ligand | Modulates Nodal signaling in development |
| PCSK9 | Proprotein convertase | Regulates NODAL signaling and proliferation in hiPSCs |
| EBAF | Nodal-related factor | Role in placental development and diabetic pregnancy |
| TDGF1 (Cripto) | Co-receptor for Nodal | Essential for Nodal signaling; cancer stem cell marker |
| BMP4 | Cross-talking BMP ligand | Regulated by Nodal in pluripotency pathway |
How Is nodal signaling pathway Regulated?
Nodal signaling is tightly regulated at multiple levels. Extracellular antagonists such as Lefty1, Lefty2, and Cerberus bind Nodal or its receptors to dampen the signal. Intracellularly, inhibitory SMADs (SMAD6 and SMAD7) interfere with receptor-SMAD interactions. Cross-talk with other pathways, including BMP and MAPK, further modulates the pathway's strength and duration. In human induced pluripotent stem cells, PCSK9 has been shown to regulate NODAL signaling and cellular proliferation, adding a metabolic layer of control. Additionally, timely inhibition of TGF-β signaling is required for notochord induction, indicating that the pathway must be switched off at specific developmental windows.
nodal signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NODAL | Breast cancer vasculogenic mimicry | Knockout breast cancer cell line (e.g., MDA-MB-231) |
| SMAD2 | Cancer progression, developmental defects | Point mutation knock-in in cancer cells |
| SMAD3 | Cancer, fibrosis | Knockout in fibroblasts or cancer cells |
| PCSK9 | Metabolic regulation in hiPSCs | Overexpression in human induced pluripotent stem cells |
| EBAF | Diabetic placental dysfunction | Knockdown in placental trophoblast cells |
Cancer progression and vasculogenic mimicry
Dysregulated Nodal signaling promotes aggressive cancer phenotypes. In breast cancer, Nodal signaling enhances vasculogenic mimicry formation through the Smad2/3 pathway, contributing to tumor blood supply and metastasis. This makes components of the pathway potential therapeutic targets.
Developmental disorders and left-right asymmetry defects
Mutations in Nodal signaling components cause severe developmental defects, including abnormal left-right patterning and mesoderm deficiencies. The pathway's conserved role in axis formation underscores its clinical relevance for congenital anomalies.
Placental development and diabetic pregnancy
The EBAF/Nodal/p27 signaling axis has been implicated in placental development, and its dysregulation is associated with diabetic pregnancy in rats. This highlights the pathway's role beyond embryogenesis in reproductive health.
Stem cell pluripotency and metabolic regulation
Nodal signaling regulates the BMP pluripotency pathway in mouse embryonic stem cells, and PCSK9 modulates NODAL signaling in human induced pluripotent stem cells. These findings link nodal signaling to stem cell maintenance and metabolic disorders.
From nodal signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NODAL affect mesoderm induction? | NODAL knockout human embryonic stem cells |
| Does a specific SMAD2 mutation alter transcriptional output? | SMAD2 point-mutation knock-in cell line |
| Can Nodal signaling be monitored in live cells? | SMAD2-GFP knock-in reporter cell line |
| Does overexpression of PCSK9 enhance NODAL signaling? | PCSK9 overexpression in hiPSCs |
| Which genes are regulated by Nodal in cancer? | SMAD3 knockout breast cancer cells followed by RNA-seq |
| Does EBAF knockdown affect placental development? | EBAF knockdown in trophoblast cell line |
How to Study the nodal signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptome changes | Identify Nodal target genes in cancer or stem cells |
| Phospho-SMAD Western blot | SMAD2/3 phosphorylation levels | Assess pathway activation after ligand treatment |
| Immunofluorescence | Subcellular localization of SMADs | Visualize nuclear translocation |
| CRISPR knockout screen | Gene essentiality and pathway modifiers | Discover novel regulators of Nodal signaling |
| Luciferase reporter assay | Transcriptional activity of Nodal targets | Quantify pathway output in high-throughput format |
| Co-immunoprecipitation | Protein-protein interactions | Detect SMAD complex formation |
| Live-cell imaging | Real-time dynamics of SMAD movement | Track pathway activation kinetics |
| Proteomics | Protein expression and post-translational modifications | Unbiased profiling of pathway components |
Transcriptomic profiling by RNA-seq
RNA sequencing can identify global transcriptional changes downstream of nodal signaling. For example, comparing wild-type and SMAD3-knockout breast cancer cells reveals target genes involved in vasculogenic mimicry.
Phospho-SMAD immunoblotting and imaging
Western blotting with phospho-SMAD2/3-specific antibodies measures pathway activation. Immunofluorescence can visualize nuclear translocation of SMAD complexes, providing spatial information.
CRISPR-based genetic screens
Pooled CRISPR knockout screens targeting nodal signaling components can uncover modifiers of pathway activity and identify synthetic lethal interactions in cancer cells.
Reporter assays and live-cell imaging
Luciferase reporters driven by Nodal-responsive promoters (e.g., Mixl1, Lefty) allow quantitative measurement of pathway activity. Live-cell imaging of fluorescently tagged SMAD2 can track dynamics in real time.
How CRISPR Can Be Used to Study GO:0038092 nodal signaling pathway
Knockout
CRISPR knockout of NODAL, SMAD2, SMAD3, or receptors such as ACVR1B can abolish nodal signaling, providing a clean background to study its loss-of-function phenotypes in development and cancer.
Point Mutation
Introducing specific point mutations in SMAD2 or SMAD3 (e.g., phosphorylation site mutants) via CRISPR base editing or HDR allows dissection of phosphorylation-dependent versus independent functions.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous SMAD2 or NODAL loci enables real-time tracking of protein localization and dynamics without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of NODAL, PCSK9, or constitutively active receptors can hyperactivate the pathway to study gain-of-function effects in stem cells and cancer models.
How EDITGENE Supports nodal signaling pathway Research
Researchers studying nodal signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, development, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models that enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for nodal signaling pathway research.
Frequently Asked Questions About nodal signaling pathway
What is the nodal signaling pathway?
The nodal signaling pathway (GO:0038092) is a conserved TGF-β superfamily cascade initiated by Nodal protein binding to activin receptors, leading to SMAD2/3 activation and transcriptional regulation.
What genes are involved in nodal signaling pathway?
Key genes include NODAL, ACVR1B, ACVR2A, ACVR2B, SMAD2, SMAD3, SMAD4, FOXH1, LEFTY1, LEFTY2, CER1, GDF1, GDF3, and TDGF1.
What is the role of nodal signaling in embryonic development?
It establishes dorso-ventral and left-right axes, induces mesoderm and endoderm, and is required for notochord formation in deuterostomes.
How is nodal signaling regulated?
It is regulated by extracellular antagonists (Lefty, Cerberus), inhibitory SMADs, and cross-talk with BMP and MAPK pathways.
What diseases are associated with nodal signaling dysregulation?
Dysregulated nodal signaling is linked to cancer progression, developmental defects, placental dysfunction, and metabolic disorders in stem cells.
What is the GO ID for nodal signaling pathway?
The Gene Ontology ID is GO:0038092.
Which receptors mediate nodal signaling?
Nodal signals through type I activin receptors (e.g., ACVR1B/ALK4) and type II receptors (ACVR2A/ACVR2B).
How can I study nodal signaling using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect gene function in the pathway.
What are downstream targets of nodal signaling?
Targets include genes involved in mesoderm induction, left-right asymmetry, and pluripotency, such as Lefty and Mixl1.
Is nodal signaling conserved across species?
Yes, nodal signaling is conserved in deuterostomes for axis formation.
Conclusion
The nodal signaling pathway (GO:0038092) is a fundamental biological process that orchestrates embryonic axis formation, cell fate specification, and tissue patterning. Its dysregulation contributes to cancer and developmental disorders, making it a critical area of research. Advances in CRISPR-based models and multi-omics approaches continue to unravel the complexities of this pathway, offering new opportunities for therapeutic intervention.
References
- 1. Luo K. 2017. Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways.. Cold Spring Harb Perspect Biol 9(1) PMID: 27836834
- 2. Duboc V et al.. 2008. A conserved role for the nodal signaling pathway in the establishment of dorso-ventral and left-right axes in deuterostomes.. J Exp Zool B Mol Dev Evol 310(1):41-53 PMID: 16838294
- 3. Schier AF. 2003. Nodal signaling in vertebrate development.. Annu Rev Cell Dev Biol 19:589-621 PMID: 14570583
- 4. Roudaut M et al.. 2021. PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs.. Stem Cell Reports 16(12):2958-2972 PMID: 34739847
- 5. Gao Q et al.. 2022. Role of EBAF/Nodal/p27 signaling pathway in development of placenta in normal and diabetic rats.. Dev Biol 481:172-178 PMID: 34737126
- 6. Rito T et al.. 2025. Timely TGFβ signalling inhibition induces notochord.. Nature 637(8046):673-682 PMID: 39695233
- 7. Gong W et al.. 2016. Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.. Oncotarget 7(43):70152-70167 PMID: 27659524
- 8. Galvin KE et al.. 2010. Nodal signaling regulates the bone morphogenic protein pluripotency pathway in mouse embryonic stem cells.. J Biol Chem 285(26):19747-56 PMID: 20427282
